Header Logo

Connection

NAVAL DAVER to Alanine Transaminase

Back to Details
This is a "connection" page, showing publications NAVAL DAVER has written about Alanine Transaminase.
NAVAL DAVER
Connection Strength
0.050
Alanine Transaminase
  1. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial. Lancet Haematol. 2023 Jan; 10(1):e24-e34.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.